<DOC>
	<DOCNO>NCT01887171</DOCNO>
	<brief_summary>The purpose study determine whether Tacrolimus add histidine-tryptophan-ketoglutarate ( HTK ) solution give intraportal intraarterial infusion back-table procedure capable reduce degree early allograft liver dysfunction , assess postoperative level aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , first 7 postoperative day serum histochemical marker liver injury inflammation .</brief_summary>
	<brief_title>Evaluation Preimplantation Portal Vein Hepatic Artery Flushing With Tacrolimus</brief_title>
	<detailed_description>Early allograft liver dysfunction remain significant complication cadaveric liver transplantation resource consume costly treatment , increase risk multiorgan failure 6-months mortality . Ischemic reperfusion injury ( IRI ) main reason early allograft liver dysfunction . Inflammatory response brain death donor precipitate extent dysfunction reperfusion recipient ( 1 ) . Clear inflammatory pathway response IRI report associate early allograft liver dysfunction ( 2,3 ) . It show ex vivo intraportal tacrolimus perfusion suppress inflammation immune response transplant liver genome-wide basis ( 4 ) . We hypothesize Tacrolimus add HTK solution give intraportal intraarterial back-table infusion capable reduce degree early allograft liver dysfunction , assess incidence postreperfusion hyperfibrinolysis , postoperative level AST , ALT , 1-7 postoperative day well serum histochemical marker liver injury inflammation compare intraportal intraarterial back-table infusion .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Flushing</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Donor : age 1565 year macrovesicular steatosis &lt; 40 % ( macroscopy biopsy ) sodium &lt; 165 mmol/l ICU stay ventilation &lt; 11 day cold ischemia time &lt; 13 hour AST &lt; 200 U/l ALT &lt; 200 U/l bilirubin &lt; 50 Î¼mol/l application norepinephrine allow Recipient age : 1869 Recipient : live donor liver transplant reduce split graft multi organ failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Liver transplantation</keyword>
	<keyword>Early allograft dysfunction</keyword>
	<keyword>Ischemic reperfusion injury</keyword>
	<keyword>Portal arterial ex vivo HTK flush</keyword>
</DOC>